These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34124201)

  • 1. Global Circumferential Strain by Cardiac Magnetic Resonance Tissue Tracking Associated With Ventricular Arrhythmias in Hypertrophic Cardiomyopathy Patients.
    Pu C; Fei J; Lv S; Wu Y; He C; Guo D; Mabombo PU; Chooah O; Hu H
    Front Cardiovasc Med; 2021; 8():670361. PubMed ID: 34124201
    [No Abstract]   [Full Text] [Related]  

  • 2. The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease.
    Liu S; Li Y; Zhao Y; Wang X; Wu Z; Gu X; Xu B; Li Y; Tian J; Cui J; Wang G; Yu B
    Front Cardiovasc Med; 2022; 9():865615. PubMed ID: 35647085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of cardiac magnetic resonance mechanical parameters for myocardial fibrosis in hypertrophic cardiomyopathy with preserved left ventricular ejection fraction.
    Hou X; Xiong X; Li X; Bi J; Xu G; Wang Y; Jiang S
    Front Cardiovasc Med; 2022; 9():1062258. PubMed ID: 36588558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy.
    Haland TF; Almaas VM; Hasselberg NE; Saberniak J; Leren IS; Hopp E; Edvardsen T; Haugaa KH
    Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):613-21. PubMed ID: 26873460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients.
    Yue X; Yang L; Wang R; Chan Q; Yang Y; Wu X; Ruan X; Zhang Z; Wei Y; Wang F
    Front Cardiovasc Med; 2022; 9():1017097. PubMed ID: 36330005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of myocardial strain on myocardial infarction size by cardiac magnetic resonance imaging in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction.
    Wang Q; Wang J; Ma Y; Wang P; Li Y; Tian J; Yue X; Su G; Li B
    Front Pharmacol; 2022; 13():1015390. PubMed ID: 36313364
    [No Abstract]   [Full Text] [Related]  

  • 8. Advanced myocardial characterization in hypertrophic cardiomyopathy: feasibility of CMR-based feature tracking strain analysis in a case-control study.
    Yang L; Zhang L; Cao S; Gao C; Xu H; Song T; Zhang X; Wang K
    Eur Radiol; 2020 Nov; 30(11):6118-6128. PubMed ID: 32588208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
    Hinojar R; Fernández-Golfín C; González-Gómez A; Rincón LM; Plaza-Martin M; Casas E; García-Martín A; Fernandez-Mendez MA; Esteban A; Nacher JJJ; Zamorano JL
    Int J Cardiol; 2017 Dec; 249():467-472. PubMed ID: 29121751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mean Scar Entropy by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Associated With Ventricular Arrhythmias Events in Hypertrophic Cardiomyopathy.
    Ye Y; Ji Z; Zhou W; Pu C; Li Y; Zhou C; Hu X; Chen C; Sun Y; Huang Q; Zhang W; Qian Y; Ren H; Yu F; Jiang C; Mao Y; Wang B; Augusto JB; Lai D; Hu H; Fu GS
    Front Cardiovasc Med; 2021; 8():758635. PubMed ID: 34869672
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced myocardial septal function assessed by cardiac magnetic resonance feature tracking in patients with hypertrophic obstructive cardiomyopathy: associated with histological myocardial fibrosis and ventricular arrhythmias.
    Song Y; Bi X; Chen L; Yang K; Chen X; Dong Z; Wang J; Kong X; Zhao K; Wang H; Duru F; Lu M; Ma L; Qiao S; Zhao S
    Eur Heart J Cardiovasc Imaging; 2022 Jul; 23(8):1006-1015. PubMed ID: 35167663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction.
    Li Y; Liu J; Cao Y; Han X; Shao G; Zhou X; Gu J; Liu T; Cui Y; Shi H
    Sci Rep; 2021 Feb; 11(1):4297. PubMed ID: 33619345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study.
    Negri F; Muser D; Driussi M; Sanna GD; Masè M; Cittar M; Poli S; De Bellis A; Fabris E; Puppato M; Grigoratos C; Todiere G; Aquaro GD; Sinagra G; Imazio M
    Int J Cardiol; 2021 Dec; 345():61-67. PubMed ID: 34728259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmental longitudinal strain as the most accurate predictor of the patchy pattern late gadolinium enhancement in hypertrophic cardiomyopathy.
    Wabich E; Dorniak K; Zienciuk-Krajka A; Nowak R; Raczak G; Daniłowicz-Szymanowicz L
    J Cardiol; 2021 May; 77(5):475-481. PubMed ID: 33246844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.
    Neisius U; Myerson L; Fahmy AS; Nakamori S; El-Rewaidy H; Joshi G; Duan C; Manning WJ; Nezafat R
    PLoS One; 2019; 14(8):e0221061. PubMed ID: 31433823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of longitudinal and circumferential contraction in relation to late gadolinium enhancement in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction.
    Sakamoto K; Oyama-Manabe N; Manabe O; Aikawa T; Kikuchi Y; Sasai-Masuko H; Naya M; Kudo K; Kato F; Tamaki N; Shirato H
    Jpn J Radiol; 2018 Feb; 36(2):103-112. PubMed ID: 29119456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary study on the diagnostic value of cardiac magnetic resonance feature tracking for malignant ventricular arrhythmias in non-ischemic dilated cardiomyopathy.
    Song L; Zhao X; Lv W; Zeng J; Wang Y; Gong B; Kalogeropoulos AP; Pu H; Bai Y; Peng S
    Ann Transl Med; 2022 Feb; 10(4):215. PubMed ID: 35280384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of left ventricular global and segmental strain parameters by cardiovascular magnetic resonance tissue tracking in light-chain cardiac amyloidosis and hypertrophic cardiomyopathy.
    Wang F; Xu X; Wang Q; Yu D; Lv L; Wang Q
    Quant Imaging Med Surg; 2023 Jan; 13(1):449-461. PubMed ID: 36620161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of left atrial strain analysis in adverse clinical events in patients with hypertrophic cardiomyopathy: a CMR study.
    Tian D; Zhang J; He Y; Xiong Z; Zhao M; Hu S; Song Q; Li Z
    BMC Cardiovasc Disord; 2023 Jan; 23(1):42. PubMed ID: 36690952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.